Biogen
BIIB
BIIB
1,010 hedge funds and large institutions have $37.6B invested in Biogen in 2019 Q2 according to their latest regulatory filings, with 84 funds opening new positions, 317 increasing their positions, 451 reducing their positions, and 142 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
27% less funds holding in top 10
Funds holding in top 10: 22 → 16 (-6)
30% less repeat investments, than reductions
Existing positions increased: 317 | Existing positions reduced: 451
41% less first-time investments, than exits
New positions opened: 84 | Existing positions closed: 142
Holders
1,010
Holding in Top 10
16
Calls
$883M
Puts
$1.2B
Top Buyers
| 1 | +$357M | |
| 2 | +$258M | |
| 3 | +$199M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$182M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
+$151M |
Top Sellers
| 1 | -$541M | |
| 2 | -$330M | |
| 3 | -$218M | |
| 4 |
JP Morgan Chase
New York
|
-$199M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$193M |